LAMISIL by is a Otc medication manufactured, distributed, or labeled by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. Drug facts, warnings, and ingredients follow.
NDC: 0067-6296-01
TERBINAFINE HYDROCHLORIDE SOLUTION 1% - ANTIFUNGAL
LAMISILAT®SPRAY
Clinically proven to cure most athlete’s foot between the toes
Full prescription strength
Relieves itching, burning, cracking and scaling
Net Contents 125 ml (4.2 fl oz)
The only 1 week (twice a day)athlete’s foot spray
Trademarks are owned by or licensed to the GSK group of companies.
1-800-330-9876
Distributed by:
GSK Consumer Healthcare,
Warren, NJ 07059
©2017 GSK or its licensor.
13059
LAMISIL
AT
terbinafine hydrochloride aerosol, spray |
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
LAMISIL 85528483 4256554 Live/Registered |
Novartis AG 2012-01-30 |
LAMISIL 77394986 not registered Dead/Abandoned |
Novartis AG 2008-02-12 |
LAMISIL 73786484 1567931 Live/Registered |
SANDOZ AG (SANDOZ LTD., SANDOZ S.A.) 1989-03-13 |
LAMISIL 73769411 not registered Dead/Abandoned |
SANDOZ PHARMACEUTICALS CORPORATION 1988-12-14 |